# Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.

> **NCT02010021** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT02010021
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-12-08
- **Final completion:** 2017-12-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010021, "Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02010021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*